E
Rallybio Corporation RLYB
$0.626 $0.0325.39% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -9.70M -9.44M -11.04M -11.47M -16.24M
Total Depreciation and Amortization 26.00K 28.00K 30.00K 32.00K 34.00K
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 1.75M 2.26M 2.08M 2.32M 1.99M
Change in Net Operating Assets -450.00K -3.05M -925.00K -4.43M 3.80M
Cash from Operations -8.38M -10.21M -9.86M -13.55M -10.42M
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 3.04M 11.08M -1.57M 22.21M 2.60M
Cash from Investing 3.04M 11.08M -1.57M 22.21M 2.60M
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 10.00K -- 18.00K 0.00 5.45M
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- 0.00 -11.00K -257.00K
Cash from Financing 10.00K -- 18.00K -11.00K 5.19M
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -5.33M 876.00K -11.42M 8.65M -2.63M